Skip to main content
Caplight Logo









AceLink Therapeutics

AceLink Therapeutics

Private
Newark, CaliforniaHealthcare & Life Scienceshttps://acelinktherapeutics.com/

Last Round

Series A

May 1, 2021

Total Funding Raised

$10M

Company Overview

AceLink Therapeutics is a clinical-stage biopharmaceutical company that develops therapies for diseases of glycolipid metabolism.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

substrate reduction therapySRTGCS inhibitorlysosomal storage disorderssmall molecule drugsFabry diseaseGaucher diseaserare genetic diseasesorphan drugsoral therapeuticsclinical-stage biopharmaAutosomal Dominant Polycystic Kidney DiseaseADPKDglucosylceramide synthase inhibitorglycolipid biologyNRF2 activatorParkinson's disease

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AceLink Therapeutics Comparables

Compare AceLink Therapeutics with similar companies based on industry and business-model similarity.

AceLink Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Azafaros
80%
Idorsia Ltd.
75%
Sanofi
72%

AceLink Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 1, 2021
SeedJul 1, 2019

AceLink Therapeutics Investors

Notable investors and investment history

AceLink Therapeutics investors
InvestorRounds
Kaitai CapitalSeed, Series A
Viva BioInnovatorSeed, Series A
Shengshan Asset ManagementSeed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 2, 2026

    Monthly visitors increased 111% MoM, reaching 1.5K.

  • May 2, 2025

    Monthly visitors grew 70% MoM, reaching 1K.

AceLink Therapeutics Filings

Explore SEC and related filing metadata, where available.

AceLink Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about AceLink Therapeutics's valuation, stock price, and market status.

Is AceLink Therapeutics a public or private company?

AceLink Therapeutics is a private company.

What is the current stock price of AceLink Therapeutics?

AceLink Therapeutics is a private company with no public stock price. No recent secondary market data is available.

How much is AceLink Therapeutics worth (valuation)?

Valuation information for AceLink Therapeutics is not publicly available.

Can I buy AceLink Therapeutics stock?

AceLink Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was AceLink Therapeutics's last funding round?

Funding round information for AceLink Therapeutics is not publicly available.

Who are the main investors in AceLink Therapeutics?

Investor information for AceLink Therapeutics is not publicly disclosed.

Will AceLink Therapeutics IPO soon?

No public IPO plans have been announced for AceLink Therapeutics.

How can I track AceLink Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AceLink Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNewark, California
Employee Range2
Year Founded2018
Last FundingMay 1, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?